AARD
NASDAQ · Pharmaceuticals
Aardvark Therapeutics Inc
$1.17
+0.06 (+5.41%)
Open$1.10
Previous Close$1.11
Day High$1.18
Day Low$1.09
52W High$16.60
52W Low$0.93
Volume—
Avg Volume3.02M
Market Cap24.29M
P/E Ratio—
EPS$-3.21
SectorPharmaceuticals
Analyst Ratings
Buy
17 analysts
Price Target
+2,142.7% upside
Current
$1.17
$1.17
Target
$26.24
$26.24
$21.03
$26.24 avg
$41.18
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 44.31M | 42.19M | 44.45M |
| Net Income | 12.13M | 10.07M | 10.99M |
| Profit Margin | 27.4% | 23.9% | 24.7% |
| EBITDA | 17.61M | 17.80M | 18.44M |
| Free Cash Flow | 9.43M | 7.96M | 8.12M |
| Rev Growth | -1.8% | +11.1% | +14.2% |
| Debt/Equity | 0.60 | 0.62 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |